￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Ivonib (ivitinib)/azacitidine combination shows clinical benefit in IDH1 mutant AML

2026-02-01 22:25:32

Check Details
Early application study of ivonib (ivitinib) in patients with acute pancreatitis

2026-02-01 22:25:32

Check Details
Ivonib (Ivitinib) Significantly Reduces Triazole Levels in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome

2026-02-01 22:25:32

Check Details
Clinical application of ivonib (ivitinib) in the treatment of insulin-resistant type 1 diabetes

2026-02-01 22:25:32

Check Details
What is the manufacturer of avatrombopag (Sucoxin)?

2026-02-01 22:25:32

Check Details
Avatrombopag (Sucoxin) Instructions

2026-02-01 22:25:32

Check Details
Avatrombopag (Sucoxin) usage and dosage

2026-02-01 22:25:32

Check Details
How many days does avatrombopag (Su Kexin) take to increase platelets and take effect?

2026-02-01 22:25:32

Check Details
Avatrombopag (Su Kexin) is not reimbursed by medical insurance

2026-02-01 22:25:32

Check Details
What does dasatinib treat?

2026-02-01 22:25:32

Check Details
What are the common side effects of dasatinib?

2026-02-01 22:25:32

Check Details
What should I pay attention to while taking dasatinib?

2026-02-01 22:25:32

Check Details
Category
相关知识